From 2019-2021, 472 people were newly diagnosed with pulmonary TB. Of these, 390 (82%) had delayed treatment, 233 (49%) were men, 288 (61%) had lung tissue decay, 50 (11%) had diabetes mellitus, and 18 (4%) had HIV. Additionally, 196 (42%) had been diagnosed in 2019 before COVID-19. The proportion with presentation-delay was similar before and during the COVID-19 pandemic (83% vs. 82%, respectively, p=0.8). However, the proportion with provider-delay was significantly higher before than during the pandemic (44% vs. 34%, p=0.02). There was no statistical difference in median days of presentation-delay before (60 days; interquartile range [IQR]: 15–541) and after (60 days; IQR: 15–360, p=0.6) the pandemic, nor in median days of provider-delay before (7 days; IQR: 4–336) and after (7  days; IQR: 4–225, p=0.6) the pandemic.